Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 191   

Articles published

PFE 29.26 -0.21 (-0.71%)
price chart
Why Pfizer (PFE) Stock Is Lower Today
"We rate PFIZER INC (PFE) a BUY. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover.
Stocks to Watch: Merck, UPS, Pfizer
Among the companies with shares expected to actively trade in Tuesday's session are Merck & Co., United Parcel Service Inc. and Pfizer Inc. Merck said its second-quarter earnings surged thanks to a one-time gain that masked a decline in revenue.
Drugmakers Merck, Pfizer Eke Out Profit Hikes  24/7 Wall St.
Merck CEO Seeks Drug Add-Ons, Not Large Tax-Inversion Deals  Bloomberg
Related articles »  
Pfizer to Acquire InnoPharma, Inc.
NEW YORK and PISCATAWAY, N.J., Jul 16, 2014 (BUSINESS WIRE) -- Pfizer Inc. (NYSE:PFE) and InnoPharma, Inc., a privately held pharmaceutical development company, today announced that they have entered into an agreement under which Pfizer will ...
Pfizer Eyes InnoPharma, Acquisition to Boost Injectables Biz - Analyst Blog  NASDAQ
Related articles »  
UPDATE: Pfizer, Inc. (PFE) Tops Q2 EPS by 1c
Pfizer, Inc. (NYSE: PFE) reported Q2 EPS of $0.58, $0.01 better than the analyst estimate of $0.57. Revenue for the quarter came in at $12.8 billion versus the consensus estimate of $12.49 billion.
Why There's Far More To Pfizer Than Viagra
In bygone centuries, medicine consisted of bloodletting and leeches. Cures were simple and inexpensive, if petrifying. But with the modern development of pharmaceuticals, and the human predilection for consuming a pill over having a malfunctioning body ...
Related articles »  
Pfizer Inc. (PFE) Q2 Earnings Preview: A Penny Here a Penny There
Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m.
Pfizer Still Looking to Buy; Results Beat Views -- 2nd Update
Pfizer Inc. said Tuesday it was looking at potential deals, including big ones, after earlier dropping its pursuit of British rival AstraZeneca PLC.
Market Update (NYSE:PFE): Pfizer Enters Into Agreement to Acquire Baxter's ...
Summary (NYSE:PFE) : Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products.
Pfizer Inc. To Go Ex-Dividend on July 30th (PFE)
Pfizer logo Pfizer (NYSE:PFE) declared a quarterly dividend on Thursday, June 26th, American Banking and Market News reports.
Pfizer's 2Q profit sinks 79 pct but tops forecasts
Pfizer's second-quarter earnings plunged 79 percent from last year, when the world's second-largest drugmaker booked a $10 billion-plus gain from a business spinoff.